Page 92 - GlaxoSmithKline Pharmaceuticals AR 2012
Basic HTML Version
88
Notes to the Consolidated Financial Statements for the year ended 31st December, 2012
continued
46
The foreign currency outstanding balances that have not been hedged by any derivative instrument or otherwise as at the Balance
Sheet date are as follows:
Rupees in lakhs
Particulars
Pound
Sterling
United
States
Dollar
Euro Japanese
Yen
Singapore
Dollar
UAE
Dirham
Australian
Dollar
Swiss
Franc
Chinese
Yuan
Malaysian
Ringgit
Thailand
Baht
Receivables
5.25 14,27.21 6,71.19
0.54
0.15
0.01
0.01
0.01
(1.64) (10,03.56) (4,28.85)
(1.52)
(0.18)
(29.33)
Payables
9,74.36 27,09.67
78.34
25.59
(14,56.95) (50,97.13)
(42.40)
(2.49)
(29.32)
(Figures in brackets pertain to the year 2011)
47
Disclosures as required by Accounting Standard 19, Leases, notified under sub-section (3C) of Section 211 of the Companies Act,
1956, are given below:
(i) The Company has taken various residential, office and godown premises under operating lease or leave and licence agreements.
These are not non-cancellable and range between 11 months and 3 years under leave and licence, or longer for other leases and
are renewable by mutual consent on mutually agreeable terms. The Company has given refundable interest free security deposits
under certain agreements.
(ii) Lease payments are recognised in the Statement of Profit and Loss under Rent in Note 37.
48
Earnings per share
Previous year
Net Profit
Rupees in lakhs
561,88.04
428,58.75
Weighted average number of shares
..
..
..
Nos.
8,47,03,017
8,47,03,017
Earnings per share (Basic and Diluted)
..
..
..
Rs.
66.34
50.60
Face value per share
..
..
..
..
..
Rs.
10
10
49
Advance income-tax (net) represents payments in excess of provisions of Rs. 2801,65.35 lakhs (Previous year - Rs. 2504,09.08 lakhs)
and includes a net tax refund with interest of Rs. 110,35.00 lakhs which has been held as provision pending the final outcome
of a litigation.
50
The tax year for the Company and BSL being the year ending 31st March, the provision for taxation for the year is the aggregate of the
provision made for the three months ended 31st March, 2012 and the provision based on the figures for the remaining nine months up to
31st December, 2012, the ultimate tax liability of which will be determined on the basis of the figures for the period 1st April, 2012
to 31st March, 2013.
51
The consolidated financial statements have been prepared in accordance with Accounting Standard (AS-21)
Consolidated Financial
Statements
. Notified under sub-section (3C) of Section 211 of the Companies Act, 1956.
52
Previous year figures
The consolidated financial statements for the year ended December 31, 2011 had been prepared as per the then applicable, pre-revised
Schedule VI to the Companies Act, 1956. Consequent to the notification of Revised Schedule VI under the Companies Act, 1956,
the financial statements for the year ended December 31, 2012 are prepared as per Revised Schedule VI. Accordingly, the previous year
figures have also been reclassified to conform to this years classification. The adoption of Revised Schedule VI for previous year figures
does not impact recognition and measurement principles followed for preparation of consolidated financial statements.
The accompanying notes are an integral part of the consolidated financial statements.
For Price Waterhouse & Co., Bangalore
Firm Registration No. 007567S
Chartered Accountants
Asha Ramanathan
Partner
Membership No. 202660
For and on behalf of the Board
Vice-Chairman
V. THYAGARAJAN
Managing Director
Dr. H. B. JOSHIPURA
Senior Executive Director
M. B. KAPADIA
Company Secretary
A. A. NADKARNI
Mumbai, 19th February, 2013
Mumbai, 19th February, 2013
